Literature DB >> 8229690

Application of neural networks to pharmacodynamics.

P Veng-Pedersen1, N B Modi.   

Abstract

Neural networks (NN) are computational systems implemented in software or hardware that attempt to simulate the neurological processing abilities of biological systems. A synopsis is presented of the operational characteristics, structures, and applications of NN. The NN technology has primarily been aimed at recognition science (e.g., handwriting, voice, signal, picture, image, pattern, etc.). It is pointed out that NN may also be particularly suitable to deal with pharmacokinetic (PK) and pharmacodynamic (PD) systems, especially in cases such as multivariate PK/PD population kinetics when the systems are so complex that modeling by a conventional structured model building technique is very troublesome. The main practical advantage of NN is the intrinsic ability to closely emulate virtually any multivariate system, including nonlinear systems, independently of structural/physiologic relevance. Thus, NN are most suitable to model the behavior of complex kinetic systems and unsuitable to model the structure. In a practical sense, this structure limitation may be inconsequential because NN in its multivariate formulation may consider any physiologic, clinical, or population variable that may influence the kinetic behavior. The application of NN in PD is demonstrated in terms of the ability of an NN to predict, by extrapolation, the central nervous system (CNS) activity of alfentanil. The drug was infused by a complex computer-controlled infusion scheme over 180 min with simultaneous recording of the CNS effect quantified by a fast Fourier transform power spectrum analysis. The NN was trained to recognize (emulate) the drug input-drug effect behavior of the PD system with the input-effect data for the 180 min as a training set.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229690     DOI: 10.1002/jps.2600820910

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Empirical versus mechanistic modelling: comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbiturates.

Authors:  I S Nestorov; S T Hadjitodorov; I Petrov; M Rowland
Journal:  AAPS PharmSci       Date:  1999

2.  Papain entrapment in alginate beads for stability improvement and site-specific delivery: physicochemical characterization and factorial optimization using neural network modeling.

Authors:  Mayur G Sankalia; Rajshree C Mashru; Jolly M Sankalia; Vijay B Sutariya
Journal:  AAPS PharmSciTech       Date:  2005-09-30       Impact factor: 3.246

3.  Neural network based on adaptive resonance theory as compared to experts in suggesting treatment for schizophrenic and unipolar depressed in-patients.

Authors:  I Modai; A Israel; S Mendel; E L Hines; R Weizman
Journal:  J Med Syst       Date:  1996-12       Impact factor: 4.460

4.  Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks.

Authors:  Sam H Haidar; Steven B Johnson; Michael J Fossler; Ajaz S Hussain
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

5.  Neural network predicted peak and trough gentamicin concentrations.

Authors:  M E Brier; J M Zurada; G R Aronoff
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

6.  The novel application of artificial neural network on bioelectrical impedance analysis to assess the body composition in elderly.

Authors:  Kuen-Chang Hsieh; Yu-Jen Chen; Hsueh-Kuan Lu; Ling-Chun Lee; Yong-Cheng Huang; Yu-Yawn Chen
Journal:  Nutr J       Date:  2013-02-06       Impact factor: 3.271

Review 7.  State-of-the-Art Review of Artificial Neural Networks to Predict, Characterize and Optimize Pharmaceutical Formulation.

Authors:  Shan Wang; Jinwei Di; Dan Wang; Xudong Dai; Yabing Hua; Xiang Gao; Aiping Zheng; Jing Gao
Journal:  Pharmaceutics       Date:  2022-01-13       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.